series-a
Stage
1
Investors
About
LenioBio develops ALiCE®, a cell-free eukaryotic protein expression platform that produces complex and functional proteins rapidly without the need for living cells, enabling faster protein production and characterization in research and development.
Explore LenioBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.